ArticleOncotarget2016
mTOR pathway activation is a favorable prognostic factor in human prostate adenocarcinoma.
Suzan Stelloo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it
ArticleOncotarget2016
Suzan Stelloo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.